New-Delhi-based Breathe Well-being has raised Rs 50 crore in a Pre-Series B round co-led by 3One4 Capital, Accel and General Catalyst. The round also saw participation from FounderBank Capital and Supermorpheus.
The company will use the funds to strengthen its coaching academy, expand the core team, and scale up the technology platform to enhance customer experience.
Founded by ex-McKinsey staff Rohan Verma and ex-Accenture employee Aditya Kaicker, the health tech start-up claims to offer simple and effective alternatives to medicines to prevent, manage and reverse Type 2 Diabetes.
The company claims to be the first digital health tech platform across Asia to have published clinical evidence in 3 journals; the American Diabetes Association, European Society of Endocrinology, and the American Association of Clinical Endocrinology.
Rohan Verma, co-founder and CEO of Breathe Well-being, said, “We are eying for a Diabetes Mukt Bharat (Diabetes Free India) with the aim to reverse diabetes for one Million Indians by 2025 and we are well on track to achieve that goal. The referral is our strongest growth lever, especially in non-metros and more than half our customers come through word of mouth.”
Dr P K Goyal, MBBS, MD and DNB General Medicine, Fortis Hospital, New Delhi, said, “According to the latest guidelines by ADA, the first line of therapy for Type 2 Diabetes is diabetes education and lifestyle modifications. The biggest challenge any medical practitioner faces with diabetic patients is the time required for diabetes education and customising lifestyle modifications to create behavioural change. This is exactly where Breathe Well-being has proven to be a big boon in my practice. Complimenting my medical practice with powerful lifestyle modifications powered by Breathe is helping my patients get outstanding results for their diabetes management and remission.”